ID   TihoDUrtTCC1506
AC   CVCL_ZV61
SY   DT15/06; TCC1506
DR   GEO; GSM5720800
DR   GEO; GSM5720801
DR   GEO; GSM5720802
DR   GEO; GSM5720803
DR   GEO; GSM5720804
DR   GEO; GSM5720805
DR   GEO; GSM5720806
DR   GEO; GSM5720807
DR   GEO; GSM5720808
DR   GEO; GSM5720809
DR   GEO; GSM5720810
DR   GEO; GSM5720811
DR   Wikidata; Q98133263
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 21.3 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
RX   PubMed=32168360; DOI=10.1371/journal.pone.0230272; PMCID=PMC7069630;
RA   Packeiser E.-M., Hewicker-Trautwein M., Thiemeyer H., Mohr A.,
RA   Junginger J., Schille J.T., Murua Escobar H., Nolte I.;
RT   "Characterization of six canine prostate adenocarcinoma and three
RT   transitional cell carcinoma cell lines derived from primary tumor
RT   tissues as well as metastasis.";
RL   PLoS ONE 15:e0230272.1-e0230272.25(2020).
//
RX   PubMed=35109825; DOI=10.1186/s12935-021-02422-9; PMCID=PMC8812184;
RA   Packeiser E.-M., Taher L., Kong W.-B., Ernst M., Beck J.,
RA   Hewicker-Trautwein M., Brenig B., Schutz E., Murua Escobar H.,
RA   Nolte I.;
RT   "RNA-seq of nine canine prostate cancer cell lines reveals diverse
RT   therapeutic target signatures.";
RL   Cancer Cell Int. 22:54.1-54.21(2022).
//